Sentiment Trading

Quest Diagnostics Inc. reports strong financial performance in Q2 2025, raising guidance for the full year and boosting investor confidence.

Quest Diagnostics reports strong second-quarter financial results, with revenue up 15.2% and earnings per share increasing 21.7% year-over-year.

Quest Diagnostics Inc. has demonstrated remarkable financial prowess, with a surge in stock value, impressive long-term performance, and strong guidance for 2025, solidifying its position as a leader in the health care sector.